Manufacturer profile
Belleview Bioscience LLC
Pharmaceutical company1 products tracked
1
products tracked
70,388
total reports
2
recalls on record
80.6%
serious overall
Products
showing 1 of 1
| Product | Approved | Reports ↓ | Top signal | Recalls |
|---|---|---|---|---|
| — | 70,388 | Myelosuppression | 2 |
Recall history · 2 on record
| Date | Class | Reason | Firm |
|---|---|---|---|
| Jul 2, 2013 | II | Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1000 mg may have potentially been mislabeled as the following drug: REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: W003925, EXP: 7/1/2014. | Aidapak Services, LLC |
| Jul 2, 2013 | II | Labeling: Label Mixup: SODIUM CHLORIDE, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs: BISACODYL EC, Tablet, 5 mg, NDC 00904792760, Pedigree: AD34931_1, EXP: 5/9/2014; DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD70633_1, EXP: 5/29/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002509, EXP: 6/3/2014; SODIUM CHLORIDE, Tabl | Aidapak Services, LLC |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm.
Registration status
Some products from Belleview Bioscience LLC are not FDA-registered for human use. For unregistered substances (peptides, SARMs without human registration), no legitimate human-use supplier exists. The absence of a sourcing route is the safety information.